163 related articles for article (PubMed ID: 36203566)
1. Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program.
Farhadfar N; Newman J; Novakovich J; Barten J; Ndifon ET; Oakes J; Cody M; Pham HP; Auletta JJ; Miller JP; Devine SM; Stefanski HE
Front Immunol; 2022; 13():937900. PubMed ID: 36203566
[TBL] [Abstract][Full Text] [Related]
2. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 Pandemic.
Hsu JW; Farhadfar N; Murthy H; Logan BR; Bo-Subait S; Frey N; Goldstein SC; Horowitz MM; Lazarus H; Schwanke JD; Shah NN; Spellman SR; Switzer GE; Devine SM; Shaw BE; Wingard JR
Transplant Cell Ther; 2021 Jun; 27(6):507-516. PubMed ID: 33865804
[TBL] [Abstract][Full Text] [Related]
4. Cryopreservation of Unrelated Hematopoietic Stem Cells from a Blood and Marrow Donor Bank During the COVID-19 Pandemic: A Nationwide Survey by the Japan Marrow Donor Program.
Kanda Y; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Kodera Y
Transplant Cell Ther; 2021 Aug; 27(8):664.e1-664.e6. PubMed ID: 33964514
[TBL] [Abstract][Full Text] [Related]
5. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
6. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
7. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Connelly-Smith L; Gooley T; Roberts L; Mielcarek M; Linenberger M; Petersdorf E; Sandmaier BM; Milano F
Transplant Cell Ther; 2023 Nov; 29(11):700.e1-700.e8. PubMed ID: 37659695
[TBL] [Abstract][Full Text] [Related]
9. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
10. Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal.
Valentini CG; Chiusolo P; Bianchi M; Metafuni E; Orlando N; Giammarco S; Bacigalupo A; Sica S; Teofili L
Cytotherapy; 2021 Jul; 23(7):635-640. PubMed ID: 33423867
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cryopreservation in Unrelated Bone Marrow and Peripheral Blood Stem Cell Transplantation in the Era of the COVID-19 Pandemic: An Update from the Japan Marrow Donor Program.
Kanda Y; Doki N; Kojima M; Kako S; Inoue M; Uchida N; Onishi Y; Kamata R; Kotaki M; Kobayashi R; Tanaka J; Fukuda T; Fujii N; Miyamura K; Mori SI; Mori Y; Morishima Y; Yabe H; Atsuta Y; Kodera Y
Transplant Cell Ther; 2022 Oct; 28(10):677.e1-677.e6. PubMed ID: 35803526
[TBL] [Abstract][Full Text] [Related]
12. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
13. Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
Worel N; Shaw BE; Aljurf M; Koh M; Seber A; Weisdorf D; Schwartz J; Galeano S; Kodera Y; Eldridge PW; Hashmi S; Atsuta Y; Szer J; Saber W; Niederwieser D; Greinix HT;
Transplant Cell Ther; 2021 Mar; 27(3):270.e1-270.e6. PubMed ID: 33781537
[TBL] [Abstract][Full Text] [Related]
14. Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Fernandez-Sojo J; Azqueta C; Valdivia E; Martorell L; Medina-Boronat L; Martínez-Llonch N; Torrents S; Codinach M; Canals C; Elorza I; Parody R; Martino R; Trabazo M; Díaz de Heredia C; Ferra C; Valcárcel D; Linares M; Ancochea Á; García-Rey E; García-Muñoz N; Medina L; Castillo N; Carreras E; Villa J; Querol S
Bone Marrow Transplant; 2021 Oct; 56(10):2489-2496. PubMed ID: 34127808
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic.
Devine SM; Bo-Subait S; Kuxhausen M; Spellman SR; Bupp C; Ahn KW; Stefanski HE; Auletta JJ; Logan BR; Shaw BE
Blood Adv; 2023 Oct; 7(19):5982-5993. PubMed ID: 37036959
[TBL] [Abstract][Full Text] [Related]
16. Anti-thymocyte globulin and post-transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts.
Novitzky-Basso I; Remberger M; Chen C; Pasić I; Lam W; Law A; Gerbitz A; Viswabandya A; Lipton JH; Kim DD; Kumar R; Mattsson J; Michelis FV
Eur J Haematol; 2022 Jan; 108(1):61-72. PubMed ID: 34606661
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of allogeneic cryopreserved hematopoietic cell grafts during the Covid-19 pandemic: A National Marrow Donor Program perspective.
Devine SM
Am J Hematol; 2021 Feb; 96(2):169-171. PubMed ID: 33206414
[No Abstract] [Full Text] [Related]
18. Stem cell donor registry activities during the COVID-19 pandemic: a field report by DKMS.
Mengling T; Rall G; Bernas SN; Astreou N; Bochert S; Boelk T; Buk D; Burkard K; Endert D; Gnant K; Hildebrand S; Köksaldi H; Petit I; Sauter J; Seitz S; Stolze J; Weber K; Weber M; Lange V; Pingel J; Platz A; Schäfer T; Schetelig J; Wienand E; Geist S; Neujahr E; Schmidt AH
Bone Marrow Transplant; 2021 Apr; 56(4):798-806. PubMed ID: 33219340
[TBL] [Abstract][Full Text] [Related]
19. A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the Covid-19 pandemic.
Schmidt AH; Buk D; Bernas SN; Mengling T; Neujahr E; van den Brink MRM
Am J Hematol; 2021 Mar; 96(3):E91-E92. PubMed ID: 33368593
[No Abstract] [Full Text] [Related]
20. Characterization and Function of Cryopreserved Bone Marrow from Deceased Organ Donors: A Potential Viable Alternative Graft Source.
Johnstone BH; Woods JR; Goebel WS; Gu D; Lin CH; Miller HM; Musall KG; Sherry AM; Bailey BJ; Sims E; Sinn AL; Pollok KE; Spellman S; Auletta JJ; Woods EJ
Transplant Cell Ther; 2023 Feb; 29(2):95.e1-95.e10. PubMed ID: 36402456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
